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Abstract
A process is described to assess the commutability of a reference material (RM) intended for use 
as a calibrator, trueness control, or external quality assessment sample based on the difference in 
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bias between an RM and clinical samples (CSs) measured using 2 different measurement 
procedures (MPs). This difference in bias is compared with a criterion based on a medically 
relevant difference between an RM and CS results to make a conclusion regarding commutability. 
When more than 2 MPs are included, the commutability is assessed pairwise for all combinations 
of 2 MPs. This approach allows the same criterion to be used for all combinations of MPs included 
in the assessment. The assessment is based on an error model that allows estimation of various 
random and systematic sources of error, including those from sample-specific effects of interfering 
substances. An advantage of this approach is that the difference in bias between an RM and the 
average bias of CSs at the concentration (i.e., amount of substance present or quantity value) of the 
RM is determined and its uncertainty estimated. An RM is considered fit for purpose for those 
MPs for which commutability is demonstrated.
Background
Commutability was defined in part 1 of this series (1). This second part describes a statistical 
procedure to assess commutability based on the difference in bias between a reference 
material (RM)16 and clinical samples (CSs) measured using 2 different measurement 
procedures (MPs). This difference in bias is compared with a predefined criterion to make a 
commutability judgment. If more than 2 MPs are included in an assessment, the 
commutability is assessed pairwise for all combinations of 2 MPs. If 1 of the MPs is a 
reference measurement procedure (RMP), then commutability of the RM with each of the 
MPs can be assessed vs the RMP, and pairwise assessment among all MPs is not necessary.
As explained in part 1 of this series (1), an MP refers to a written specification for how a 
measurement is performed. A measuring system is a physical in vitro diagnostic (IVD) 
medical device manufactured according to the MP specifications and used to make 
measurements on CSs. Results for an RM and for CSs measured using different measuring 
systems are used to assess commutability of an RM. For simplicity, in this series of reports 
we use the term MP when referring to either an MP or results from a specific measuring 
system that is an IVD medical device representative of the MP.
Currently applied approaches for commutability assessment use criteria based on the 
statistical distribution of results for CSs observed between pairs of MPs. Linear regression 
with prediction interval for the CSs has been commonly used to determine whether an RM is 
commutable (2, 3). When an RM belongs to the same population as the CSs, an observation 
of the RM has a specified probability (usually set to 95%) to fall within the prediction 
interval limits. The prediction interval limits are dependent on the random errors in each MP 
and can be different for comparisons between different pairs of MPs, which prevents using a 
single criterion based on the intended use of the RM that is applicable to all MPs. Using a 
prediction interval for assessment of commutability is a test of the hypothesis that the RM 
can be considered to belong to the same population as the CSs. Not rejecting a hypothesis 
does not prove that it is true, and the prediction interval approach does not quantify how 
closely the RM agrees with the average relationship for the CSs at the concentration of 
16Nonstandard abbreviations: RM, reference material; CS, clinical sample; MP, measurement procedure; RMP, reference 
measurement procedure; IVD, in vitro diagnostic; C, commutability criterion; MSSD, mean square successive difference.
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interest. The uncertainty of the closeness of agreement is neglected in the prediction interval 
approach. An RM with a bias exactly equal to the prediction limit has a probability of 
approximately 50% to have a value within the prediction limits. For these reasons, a 
different approach is presented in this report.
An advantage of the approach described here is that the difference in bias between an RM 
and the average bias of CSs at the concentration of the RM is determined. This approach 
allows more relevant assessment of commutability being suitable for the intended use of an 
RM with the same criterion being used for all combinations of MPs included in the 
assessment. Another advantage is that the criterion to make a commutability judgment can 
be based on medically relevant differences between RM and CS results, which is not the 
case with the prediction interval approach.
In practice, an assessment of commutability cannot include all possible performance 
conditions for an MP, such as reagent lots, calibrator lots, and environmental conditions. We 
must restrict the assessment to measurements under specified conditions. In this report, the 
specified conditions are 1 run with each of the MPs using 1 lot of reagents and calibrators, 
and each MP operated and performing according to the specifications of its manufacturer. 
The conclusions about commutability of the RM are generalized to all future results using 
other IVD medical devices representative of the same MP with the assumption that other 
IVD medical devices have equivalent performance when operated under conditions such as 
different reagent and calibrator lots, maintenance, and operators. Limitations of this 
assumption were discussed in part 1 of this series (1).
A worked example and explanation of the example calculations are provided in the 
Commutability Example Calculations and Commutability Example Explanation sections of 
the Data Supplement that accompanies the online version of this article at http://
www.clinchem.org/content/vol64/issue3.
Models, Experimental Designs, and Assumptions
ASSESSMENT OF COMMUTABILITY
The experimental design considers the comparison of results, x and y, obtained by 2 MPs. In 
a typical experimental design, n CSs are measured in 1 run with each of the MPs. A simple 
model for the difference between single determinations of a CS is:
(1)
where:
μ is the true concentration of the CS
b(μ) is a common bias between the runs with the 2 MPs (the bias can be expressed by 
a continuous function of μ or a constant)
d is an error component specific for the CS (can be considered as a random 
component in a population of samples)
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ex is a within-run component of variation for MP x
ey is a within-run component of variation for MP y.
The b(μ) term is the part of the difference that can be expressed by a continuous function of 
μ. Continuous means that small changes in μ result in small changes in b(μ). The term d is a 
sample-specific difference. The SD of component d is denoted σd. The terms ey and ex are 
the within-run components of variation with SDs σe(x) and σe(y), in the following denoted σx 
and σy. Sample-specific differences can be reduced only by an improved selectivity of 1 or 
both MPs.
Ideally, the variation within runs should be completely random, and the SDs σx and σy can 
be estimated from repeated measurements. Under this ideal situation, the SD of the sample-
specific differences, σd, can be estimated according to an approach suggested by Nilsson (4). 
If the prerequisite of random variation is not satisfied, position effects within measurement 
runs must be added to the model in Eq. 1. If the replicate measurements of the CSs are 
adjacent, the σd also includes the SDs of the position effects. Miller et al. (5) suggested to 
estimate the influence of possible position effects by performing a second run with the CSs 
in a randomized order in relation to the first run.
For commutability assessment, we recommend only 1 run and that the replicate 
measurements of the CSs are adjacent, i.e., made one after the other, and that position effects 
are investigated from measurements of the RMs made in different positions. The terms b(μ) 
and σd will usually depend on the specified population of CSs. The SDs are assumed to be at 
least approximately independent of the concentration. The distributions of the error 
components are assumed to be approximately normal.
COMMUTABILITY CRITERION
Commutability of the RM concerns how close the systematic difference (the bias) between 
the 2 MPs for the RM is to the average bias for the CSs, b(μ), at the concentration of the 
RM. The difference between the bias for the RM and the average bias for the CSs is denoted 
dRM and expresses the closeness of agreement between the bias for the RM and the bias for 
the CSs.
For assessment of commutability, we need to specify a maximum value of |dRM| for the RM 
to be considered commutable. This maximum value is called the commutability criterion 
(C). For example, C can be the maximum acceptable bias when one intends to use the RM as 
a calibrator.
The SD of the contributions from the random components e and d to the differences between 
the 2 MPs, when the measured values are means of k replicates, is:
(2)
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Assuming a normal distribution, about 5% of the CS differences will be larger than 
2σRandom even if there is no bias between the measurement procedures for the CSs.
For assessment of commutability vs C, we need an estimate of dRM (for simplicity, we use 
the same symbol for the estimate) and the expanded uncertainty U(dRM) of the estimate. We 
will have 1 of the following 3 conditions:
1. The RM is commutable when the uncertainty interval dRM ± U(dRM) is within 0 
± C.
2. The RM is noncommutable when the uncertainty interval dRM ± U(dRM) is 
outside 0 ± C.
3. A commutability decision is inconclusive when the uncertainty interval dRM ± 
U(dRM) and 0 ± C are overlapping.
When U(dRM) > C, it will not be possible to verify commutability. A too large U(dRM) can 
be caused by (a) an unsuitable experimental design (too few replicates and/or number of 
CSs) or (b) poor precision and/or poor selectivity (large sample-specific differences). In the 
first case, the experimental design should be reconsidered and the experiment repeated with 
a new design. In the second case, 1 or both MPs should be excluded from the commutability 
assessment. The precision and selectivity of each MP should be known in advance and 
considered in the experimental design. As explained in part 1 of this series (1), MPs should 
be prequalified for inclusion in a commutability assessment, and MPs with inadequate 
performance should be excluded. However, sample-specific differences are estimated in this 
commutability assessment experimental design and, when excessive, can be a reason to 
exclude an MP from the data analysis and to declare that the RM is not suitable for use with 
that MP.
EXPERIMENTAL DESIGN
The experiment should be designed in such a way that it is possible to obtain a reliable 
estimate of the value dRM and the uncertainty of the estimate that is derived from an estimate 
of the bias for the RM and for the CSs and their uncertainties between 2 MPs. For 
identification of the main sources contributing to the differences between the MPs, it is also 
valuable to have estimates of the SDs for replicates, position effects, and sample-specific 
differences. To obtain these estimates, the following experimental design is recommended.
A number, n, of CSs are measured in k sequential adjacent replicates in 1 run with both 
MPs. The sequence of measuring the CSs must be randomly assigned regarding the 
concentrations (not in order of concentration) to avoid the possibility of confounding 
between the measuring order and a trend in the bias. Each RM is measured in p groups of k 
sequential adjacent replicates. The p groups shall be spread out in the run, i.e., the groups 
represent different positions in the series of measurements constituting a run. If there are 
known factors that may cause systematic differences between measurements, these factors 
must be considered in the design and statistical analysis of the experiment. For example, if a 
multichannel pipette is used for adding samples and/or reagents, it is suitable to have an 
equal number of replicates from each channel, i.e., k must at least be equal to the number of 
channels.
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The number of CSs, n, must be large enough and the concentrations “evenly” distributed in 
the interval to make it possible to distinguish between sample-specific differences and a 
common bias between the MPs expressed by the continuous function b(μ). It is not 
necessary for the CSs to cover the measuring interval of the MPs, but it is important that the 
CSs cover a reasonable concentration interval around each RM to allow a reliable estimate 
of bias between the MPs. An essential prerequisite for the statistical analysis is that the 
change in the bias function between consecutive CS concentrations is relatively small 
compared with the variation around this function in a difference plot. Whether this 
prerequisite is satisfied can usually be judged from a visual inspection of the difference plot; 
see the Transformation of the Data section. The n CSs should usually be at least 30 to satisfy 
these requirements.
The minimum number of replicates, k, is 2, but triplicate measurements are recommended to 
allow removal of an outlier without removing all data for a CS or an RM position. If 
precision of MPs is a major uncertainty source, performing a larger number of replicates 
might be necessary.
Measuring the RMs in different positions makes it possible to investigate position effects 
and better estimate the uncertainty of the bias for an RM. The uncertainty of the bias 
estimate depends on the SD of the position effects and the number of degrees of freedom 
must be adequate for the estimate of this SD. We recommend that the number of positions, 
p, should be at least 5.
The estimate of the commutability measure, dRM, must be determined with acceptable 
uncertainty. As a minimum requirement, we suggest that U(dRM) should be <C/2. The 
suggested minimum values of n, k, and p do not guarantee that this requirement is satisfied, 
but the experimental design makes it possible to identify the dominating contribution to the 
uncertainty and indicates where an improvement of the experimental design is needed. An 
example of an allocation of measurements with n = 50, k = 3, p = 5, and 5 RMs is given as 
an example in the Commutability Example Calculations, worksheet Allocation, found in the 
online Data Supplement.
TRANSFORMATION OF THE DATA
The statistical analysis uses difference plots with or without transformation of the data for 
the statistical analysis. Difference plots are preferred to regression because possible trends in 
bias or sample-specific effects over the concentration interval are better identified.
For the statistical analysis, it is an advantage if the SDs of the random components are 
independent of the concentration. This requirement is often approximately satisfied for 
either concentration or ln(concentration). Other types of transformations can be used, but the 
advantage of using ln(concentration) is that it is easy to interpret the results. If SDs and 
differences of ln(concentration) are multiplied by 100, we obtain approximate values of CVs 
and relative differences in percent for concentration. The decision whether to use 
concentration or ln(concentration) for the statistical analysis is based on the experimental 
results. A precision profile as shown in Fig. 1 can be constructed for each MP by calculating 
the SD and the mean of the replicates for each CS and plotting the SDs against the means. If 
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a precision profile does not indicate a strong (more than a factor 2) dependence between the 
SD and the concentrations, as in Fig. 1A, the SDs are pooled to a common estimate for each 
MP, denoted sx and sy, respectively. If the SDs seem to be proportional to the concentrations, 
as in Fig. 1B, it is an indication that ln(concentration) should be used; however, the next 
paragraph must also be considered.
Difference plots are examined for yi − xi and ln(yi) − ln(xi) on the y axis against xi, when 
MP x is an RMP, or when neither of the MPs is an RMP, (yi + xi)/2 on the x axis. The width 
of the scatter is caused by the combined influence of the SDs of all random components. 
From a visual inspection of the 2 difference plots, one identifies the plot where the scatter 
width has the smallest dependence on the concentration to determine whether concentration 
or ln(concentration) should be used for the statistical analysis. Fig. 2 shows difference plots 
for yi − xi and ln(yi) − ln(xi) against the mean concentration. It is obvious in this case that 
ln(concentration) is preferred because of the consistent scatter over the concentration 
interval. It is more important that the width of the scatter is independent of the concentration 
for a difference plot than for the precision profiles in the previous paragraph. If the scatter 
width is independent of the concentration but precision profiles are not independent of the 
concentration, the contributions from the SD within triplicates, σx and σy, should be 
negligible. If neither concentration nor ln(concentration) gives an approximately constant 
scatter width, the statistical analysis should be performed for different concentration 
intervals, within which the scatter width is approximately constant. When transformation to 
ln(concentration) is used, the statistical analyses are performed with the ln(concentration) 
values. In precision profiles and difference plots, it is appropriate to have concentration on 
the x axis (possibly with a logarithmic scale) and use the ln(concentration) values on the y 
axis.
The decisions whether to transform and whether to perform the statistical analysis for 
different concentration intervals are based on subjective judgments. Models and assumptions 
are always approximations of reality, and it is better to use a subjective judgment than to use 
a fixed model with no judgment at all.
HANDLING OF OUTLIERS
Outliers are observations that are distant from the main part of the observations. An outlier 
may be because of occasional problems in an MP, experimental mistakes, mix-up of results, 
transcription errors, or other types of operator errors. If such a cause is identified, the 
observation should be corrected or excluded. There may, however, be outliers for which the 
causes cannot be identified; for instance, when some of the CSs in a comparison of MPs 
have properties that cause ≥2 separate distributions of the differences between the MPs. To 
determine how close the bias for the RM is to the average bias for the CSs is not meaningful 
if the average bias represents 2 populations of CSs. The populations of CSs corresponding to 
these different distributions should, if possible, be identified (e.g., healthy and diseased 
donors) and commutability assessments performed for each population. If the outliers are 
relatively few (<10%), the only reasonable approach often is to exclude them. If the outlier 
results are not excluded, the calculation of the mean and the SD may be misleading.
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Often a visual inspection is sufficient for identification of possible outliers. Obvious outliers 
can often be identified from, for instance, precision profiles and difference plots. If there are 
borderline cases, one can perform the analysis both without and with exclusions. If inclusion 
or exclusion of potential outliers gives essentially the same estimates, the observations can 
be included.
COMPONENTS OF VARIATION WITHIN RUNS ESTIMATED FROM THE RM
For each RM, we have p positions with k replicates in each position. First, the mean and SD 
for each position are calculated. The SD of the position means is denoted sPos-mean, and the 
pooled SD of the SDs within positions is denoted se. When the number of replicates is the 
same in each position, the pooled variance is the mean of the variances in the different 
positions. The pooled SD is the square root of the pooled variance. If there are no position 
effects, both √k · sPos-mean and se should be estimates of σe (the SD within positions), and to 
test the hypothesis of no position effects, the test statistic is:
(3)
The SD of the position effects is estimated by:
(4)
When the value under the root sign is negative, (F < 1) sPos is set to 0. When > 1 RM is 
included, pooled estimates can be calculated as the square root of the mean variances. When 
calculating the pooled SD of the position effects, a negative value of the variance under the 
root sign in Eq. 4 shall not be replaced by 0.
ESTIMATE DIFFERENCES BETWEEN MPs FROM THE CSs
The analysis is performed for either concentration or ln-(concentration). In the following, xi 
and yi denote either the mean of concentration or ln(concentration) for sample i. From the 
replicates of each CS, an estimate of SD between replicates is obtained. A pooled estimate 
of the SD between replicates is obtained from all CSs by calculating the square root of the 
mean of the variances for the individual CSs. The pooled SDs between replicates are 
denoted sx and sy, respectively. If the SDs between replicates for the RM(s) do not differ 
significantly (F-test) from the pooled estimates for the CSs, then the SDs for the RM(s) can 
be included in sx and sy. Otherwise, separate estimates are used for the RM(s) and the CSs.
The differences Bi = yi − xi are plotted against the mean concentrations of the 2 MPs or 
against xi, when x represents an RMP. A difference plot can be characterized by 2 
components: a continuous function fitted to the center of the scatter and the variation around 
the function, expressed by the SD. The first component is an estimate of b(μ). The SD of the 
scatter should be σRandom, defined in Eq. 2.
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It is often reasonable to assume that the maximum difference between consecutive 
concentrations of the CSs corresponds to a maximum change of the bias function, which is 
small compared with the contribution from the within-run variation to the observed 
differences Bi. Consecutive B values should then have approximately the same expected 
mean, and we can estimate the SD around the bias function from each pair of consecutive 
values. Pooling the estimates from all the consecutive differences gives the SD estimate 
based on the mean square successive difference (MSSD).
(5)
where Bi is ordered according to ascending values of xi or (xi + yi)/2. sMSSD is used as an 
estimate of σRandom, which includes the variability associated with sample-specific 
differences and does not include the variability associated with a trend in differences. This 
estimate should be of the same size as the usual estimate of the SD of the B values, 
calculated as:
(6)
when the difference between the measurement procedures is a constant (i.e., no trend). BCS 
is the mean of the differences Bi. Thus, when sMSSD is significantly smaller than sB, a trend 
is indicated. For n > 20, the distribution of (sMSSD/sB)2 is approximately normal with mean 
1 and ; see Hald (6). This test supports the decision regardless of 
whether the bias function is constant in a concentration interval.
When there are sample-specific effects, the sMSSD is an estimate of the SD of the 
contributions from the random components e and d to the differences between the 2 MPs 
according to Eq. 2. When there are no sample-specific differences, sMSSD should be an 
estimate of:
(7)
and the hypothesis of no sample-specific differences can be tested by:
(8)
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where F has an F distribution.
With the suggested experimental design (triplicate measurements), k is equal to 3. The 
appropriate numbers of degrees of freedom in the numerator and the denominator are not 
obvious. sMSSD is estimated from n − 1 differences, but they are not independent and the 
degrees of freedom must be less than n − 1. If sMSSD is calculated from the differences 
between B2 − B1, B4 − B3, and so on, it is based on n/2 independent differences when n is 
even and (n − 1)/2 when n is odd. Thus, the number of degrees of freedom for the estimate 
sMSSD should at least be equal to the integer part of n/2, and this value is used in the test.
In the denominator in Eq. 8, we have the sum of 2 variance estimates, and the Welch–
Satterthwaite formula can be used to calculate the effective number of degrees of freedom 
(7). In this application, the minimum number of the degrees of freedom for sx and sy is used. 
By using minimum numbers of degrees of freedom both in the numerator and the 
denominator, the F-test should be conservative (i.e., the probability of incorrectly rejecting 
the hypothesis of no sample-specific differences is less than the nominal significance level).
An estimate of σd, the SD of the sample-specific differences, is obtained by:
(9)
If the expression under the root sign is negative, the estimate sd = 0 is used.
When there are no trends, sB may be used instead of sMSSD in Eq. 9.
If there are position effects, these effects are included in the estimate sd. By using the 
estimates of position effects for RMs, we can correct for these effects and obtain a corrected 
value [denoted sd(corr)]
(10)
The commutability assessment and the calculation of the expanded uncertainty U(dRM) are 
performed in the same way regardless of whether there are significant sample-specific 
differences. However, if the uncertainty is too large for a conclusive decision and the 
commutability assessment must be repeated, it is essential to identify the error component 
that gives the dominating contribution to the uncertainty. In other words, shall we increase 
the number of replicates or the number of CS or should we adjust the qualifications to 
include CS or exclude an MP from commutability assessment because of nonselectivity for 
the measurand. One of the advantages with this approach is that no assumption of a specific 
model for b(μ) is required for the estimation of the sample-specific differences. We can 
separate sample-specific differences from a common bias assumed to be a continuous 
function of the concentration.
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COMMUTABILITY OF THE RM
The commutability of the RM is assessed as the difference between the bias for the RM and 
the average bias for the CSs, b(μ), between 2 MPs at the concentration of the RM. This 
difference is denoted dRM. To obtain an estimate of dRM, we need an estimate of the bias for 
the RM and b(μ) for the CSs. The bias for the RM is estimated by the observed difference 
BRM = yRM − xRM, and the standard uncertainty is estimated by
(11)
sPos-mean(x) and sPos-mean(y) are the SDs between position means for the RMs defined in the 
Components of Variation Within Runs Estimated from the RMs section.
The appropriate estimate of b(μ) at the concentration of the RM depends on the outcome of 
the experiment. The following outcomes are possible (note that the uncertainty of BRM is the 
same):
A: The bias function b(μ) is approximately constant in the whole 
concentration interval, and the CSs bracket the concentration of the RM—b(μ) 
is estimated by BCS and the standard uncertainty by: sB
(12)
dRM is estimated by BRM − BCS with the standard uncertainty:
(13)
B: The bias function b(μ) is approximately constant in a concentration interval 
enclosing the RM—It is possible to find a concentration interval with q CSs bracketing 
the RM where b(μ) seems to be approximately constant. In this case, q must be large enough 
to give an acceptable uncertainty. We have the same situation as in A but with q CSs instead 
of n; thus, we have:
(14)
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C: The bias function b(μ) has an approximately linear trend in an interval 
where there are q/2 CSs on each side of the RM—The number q is even and must 
be large enough to give an acceptable uncertainty. The CSs should also be “evenly” 
distributed in the concentration interval.
The mean bias of the q CSs bracketing the RM is used as an approximate estimate of b(μ) at 
the concentration of the RM, but if the uncertainty is calculated according to Eq. 12, it will 
be an overestimation, as the trend in b(μ) contributes to sB. Instead of sB, it is more 
reasonable to use sMSSD according to Eq. 5, and the uncertainty is given by:
(15)
A large magnitude in the bias trend indicates a severe problem, and the commutability 
assessment may not be possible.
D: The prerequisites for situations A, B, and C are not satisfied (e.g., we have 
none or only a few CSs with concentrations close to that of the RM)—It may be 
tempting to fit a model to b(μ) and extrapolate or interpolate to the concentration interval of 
interest. Forcing the data into a model is not acceptable. With no or few CSs in the relevant 
concentration interval, we have no possibilities to verify that the model is reasonable.
DETERMINING THE COVERAGE FACTOR FOR THE UNCERTAINTY ESTIMATE
To evaluate commutability, we need the expanded uncertainty U(dRM) obtained by 
multiplying u(dRM) by a suitable coverage factor. If we want a risk of 5% to erroneously 
classify an RM just outside C as commutable, the coverage of the expanded uncertainty shall 
be 90%. An uncertainty interval dRM ± U(dRM) within 0 ± C should be equivalent to 
rejecting the hypothesis that |dRM| > C at the 5% level of significance. The standard 
uncertainties in Eqs. 13, 14, and 15 are a combination of 3 components, which makes the 
calculation of the coverage factor complicated. However, with p ≥ 4 (pooled estimates of 
sPos-mean from at least 2 RMs) and n (or q) ≥ 12, a coverage factor of 1.9 gives a coverage of 
at least 90%. This coverage factor is suggested when there are no reasons for a larger value. 
With an infinite number of degrees of freedom, the coverage factor is about 1.7. The sizes of 
n, q, and p discussed in this section concern the minimum values, which can justify a 
coverage factor of 1.9. The numbers recommended in the experimental design section meet 
these minimum sizes.
Presentation of Commutability Assessment
A suitable way to illustrate the results from a commutability assessment is shown in Fig. 3 
based on the example data provided in the online Data Supplement. The mean bias between 
the 2 MPs for the CSs is shown as a solid line (black). The dashed lines (red) are the 
commutability criteria. The squares (red) are the mean bias between the 2 MPs for the RMs, 
and the bars represent the uncertainty in the difference in bias between RM and CS mean 
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biases. RM1, RM2, and RM4 are indeterminate; RM3 is commutable; RM5 is 
noncommutable.
Commutability Assessment for More Than Two Measurement Procedures
In most cases, more than 2 MPs are included in a commutability assessment, and all 
combinations of 2 MPs are evaluated as pairs as described here and shown in Fig. 3 for 1 
pair. The commutability of an RM determined for all combinations of MPs examined can be 
presented in different ways. One convenient summary representation for all combinations of 
pairs of MPs is shown in Fig. 4A. In this example, the RM is not commutable for MP8 and 
is commutable for the other MPs in the assessment. In cases when an RMP is available for a 
measurand, all clinical laboratory MPs can be compared with the RMP (see Fig. 4B), and it 
is not necessary to compare all combinations of MP pairs with each other. Considerations for 
the fraction of MPs for which an RM should be commutable to be suitable for its intended 
use were discussed in part 1 of this series.
Conclusion
The approach to commutability assessment described here gives estimates of the differences 
in bias between RMs and CSs when 2 MPs are compared. The uncertainties of these 
estimates are also calculated. A single fixed criterion for commutability of an RM can be 
applied to all combinations of pairs of MPs. The criterion can be selected based on the 
intended use of an RM as a calibrator, trueness control, or external quality assessment 
material, and the criterion can be related to the requirements for medical decisions based on 
the laboratory test results. The commutability assessment determines whether the difference 
in bias plus its uncertainty fulfills the criterion for a conclusion that an RM is commutable, 
noncom-mutable, or indeterminate for pairs of MPs. Conclusions regarding suitability for 
use of an RM can be made by assessing its commutability for all MPs in the assessment as 
described in part 1 of this series (1).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Precision profiles as SD vs concentration
(A) shows an approximately constant SD over the concentration interval. (B) shows a 
proportional relationship between SD and concentration.
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Fig. 2. Difference in concentration (A) and ln(concentration) (B) for the same data vs mean 
concentration of both MPs
(A) is from spreadsheet tab CS_Trans found in the online Data Supplement. (B) is from 
spreadsheet tab CS_Trans (2) found in the online Data Supplement.
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Fig. 3. Difference in bias between RMs (red squares) and CSs (black diamonds) vs mean 
concentration of the 2 measuring systems
The solid black line is the mean bias between the 2 measurement procedures for the CSs. 
The red dashed lines are the commutability criteria. The red squares are the mean bias 
between the 2 MPs for the RMs, and the bars are the uncertainty in the difference in bias 
between RM and CS mean bias. RM1, RM2, and RM4 are indeterminate; RM3 is 
commutable; RM5 is noncommutable. Fig. 3 is from the spreadsheet tab CS&RM_Diff 
found in the online Data Supplement.
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Fig. 4. Summary of commutability conclusions for a RM for multiple MPs
(A) shows a representation of commutability conclusions for all combinations of pairs of 
MPs. (B) shows a representation when an RMP is available. The notation C, I, N could be 
replaced with numeric values for difference in bias and its uncertainty if desired.
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